NCT07801378

Brief Summary

Type 2 diabetes is often accompanied by high blood triglycerides and excess weight, and diet plays a central role in managing these conditions together. The purpose of this study is to compare the effects of two moderate low-carbohydrate diets - one higher in protein and one higher in fat - against a standard diet, on blood sugar control, blood lipids (especially triglycerides), body weight, and blood pressure in adults with type 2 diabetes, hypertriglyceridemia, and overweight or obesity.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 3, 2026

Completed
17 days until next milestone

Study Start

First participant enrolled

September 20, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2026

Completed
Last Updated

September 8, 2026

Status Verified

September 1, 2026

Enrollment Period

Same day

First QC Date

August 31, 2026

Last Update Submit

September 4, 2026

Conditions

Keywords

low_carbohydrate diettype 2 diabetesT2DObesitymetabolic indexeshypertriglyceridaemia

Outcome Measures

Primary Outcomes (1)

  • Change in fasting serum triglyceride (TG) level

    Baseline to Week 12

Secondary Outcomes (11)

  • Change in glycated hemoglobin (HbA1c)

    Baseline to Week 12

  • Change in fasting blood glucose (FBS)

    Baseline to Week 12

  • Change in total cholesterol

    Baseline to Week 12

  • Change in LDL-C

    Baseline to Week 12

  • Change in systolic blood pressure

    Baseline to Week 12

  • +6 more secondary outcomes

Study Arms (3)

High-Protein Low-Carbohydrate Diet

EXPERIMENTAL
Other: High-Fat Low-Carbohydrate DietOther: Standard diet

High-Fat Low-Carbohydrate Diet

EXPERIMENTAL
Other: High-Protein Low-Carbohydrate DietOther: Standard diet

Standard diet

ACTIVE COMPARATOR
Other: High-Protein Low-Carbohydrate DietOther: High-Fat Low-Carbohydrate Diet

Interventions

A calorie-restricted (500 kcal/day below baseline needs) diet providing 40% of energy from complex carbohydrates, 45% from fat (35% unsaturated with a 4:1 MUFA/PUFA ratio, 10% saturated), and 15% from protein, delivered over 12 weeks as 5 individualized daily meals.

High-Protein Low-Carbohydrate DietStandard diet

A calorie-restricted (500 kcal/day below baseline needs) standard diet providing 55% of energy from complex carbohydrates, 30% from fat (20% unsaturated with a 4:1 MUFA/PUFA ratio, 10% saturated), and 15% from protein, delivered over 12 weeks as 5 individualized daily meals.

High-Fat Low-Carbohydrate DietHigh-Protein Low-Carbohydrate Diet

A calorie-restricted (500 kcal/day below baseline needs) diet providing 40% of energy from complex carbohydrates, 30% from fat (20% unsaturated with a 4:1 MUFA/PUFA ratio, 10% saturated), and 30% from protein (15% plant-based), delivered over 12 weeks as 5 individualized daily meals.

High-Fat Low-Carbohydrate DietStandard diet

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with type 2 diabetes mellitus for at least 6 months
  • Fasting serum triglycerides between 200-399 mg/dL
  • Body mass index (BMI) between 25 and 35 kg/m\^2
  • Age between 30 and 70 years
  • If taking medication for diabetes, dyslipidemia, or hypertension, dose stable for at least 8 weeks prior to enrollment
  • Able to follow the prescribed diet
  • Willing and able to provide informed consent

You may not qualify if:

  • Fasting triglycerides of 400 mg/dL or higher, or lower than 200 mg/dL
  • HbA1c greater than 10.5%
  • eGFR less than 30 mL/min/1.73m\^2
  • Type 1 diabetes or rare metabolic disorders
  • Severe renal, cardiac, or hepatic disease, or active pancreatitis
  • Established cardiovascular disease (myocardial infarction, stroke, coronary angioplasty or bypass surgery, or heart failure)
  • Pregnancy, breastfeeding, or planning pregnancy during the study
  • Psychiatric disorder or social circumstances that would prevent adherence to the dietary protocol
  • Change in dose or type of diabetes, lipid-lowering, or blood pressure medication within 8 weeks before enrollment or during the study
  • Use of weight-loss medications, protein supplements, or probiotics
  • Body weight change greater than 3% within the past 6 months
  • Withdrawal of consent to continue participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes MellitusObesityOverweightHypertriglyceridemiaDiabetes Mellitus, Type 2

Interventions

Diet, High-Protein Low-Carbohydrate

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperlipidemiasDyslipidemiasLipid Metabolism Disorders

Intervention Hierarchy (Ancestors)

Diet, Carbohydrate-RestrictedDiet TherapyNutrition TherapyTherapeuticsDiet, High-ProteinDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

zeynab kavyani, PhD student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized in a 1:1:1 ratio to one of three parallel 12-week dietary arms: a moderate low-carbohydrate high-protein diet, a moderate low-carbohydrate high-fat diet, or a standard diet.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

August 31, 2026

First Posted

September 3, 2026

Study Start

September 20, 2026

Primary Completion

September 20, 2026

Study Completion

September 20, 2026

Last Updated

September 8, 2026

Record last verified: 2026-09